This is in sharp contrast to the recent findings reported by the Immunoscore® team whose findings strongly advocate for the quantification of CD3+ and CD8+ T cell infiltration in colorectal cancer [5,6] as prognostic markers to better define the risk of recurrence and survival, and to better guide clinicians in decisions surrounding patient treatment [61,62]. Here, CD8A is linked to colorectal cancer.